Leerink analyst warned that Moderna (NASDAQ:MRNA) shares could fall more than 30% if interim results from its Phase 3 CMV ...

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

根据AI大模型测算海普瑞后市走势。短期趋势看，连续2日被主力资金增仓。主力没有控盘。中期趋势方面，下方累积一定获利筹码。近期该股获筹码青睐，且集中度渐增。舆情分析来看，2家机构预测目标均价7.30，低于当前价-37.55%。目前市场情绪极度悲观。

On November 30th, exactly 3 years ago, Moderna’s ($MRNA) stock was priced at $352.43, but after losing 87.69% of its value, MRNA stock is priced ...

On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $42.05 which represents a decrease of $-1.61 or -3.69% from the prior close of $43.66. The stock opened at $43.13 and touched a ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

Through Nov. 22, the Nasdaq-100 is up over 23%, which is impressive for a broad index. However, it hasn't been peachy keen for all companies in the index. Here are the worst-performing stocks in the ...

Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: ...

智通财经APP讯，艾美疫苗 ...

With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial ...

Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds ...

北京时间2024年11月20日02时03分，莫德纳（MRNA.us）股票出现异动，股价大幅跳水5.01%。截至发稿，该股报37.53美元/股，成交量425.261万股， 换手率 1.11%，振幅4.38%。